90 related articles for article (PubMed ID: 7675456)
1. Involvement of RB-1, p53, p16INK4 and telomerase in immortalisation of human cells.
Whitaker NJ; Bryan TM; Bonnefin P; Chang AC; Musgrove EA; Braithwaite AW; Reddel RR
Oncogene; 1995 Sep; 11(5):971-6. PubMed ID: 7675456
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the Rb gene and cyclin-dependent kinase 4 inhibitor genes (p16INK4 and p15INK4B) in human ovarian carcinoma cell lines.
Yaginuma Y; Hayashi H; Kawai K; Kurakane T; Saitoh Y; Kitamura S; Sengoku K; Ishikawa M
Exp Cell Res; 1997 Jun; 233(2):233-9. PubMed ID: 9194486
[TBL] [Abstract][Full Text] [Related]
3. Reciprocal Rb inactivation and p16INK4 expression in primary lung cancers and cell lines.
Shapiro GI; Edwards CD; Kobzik L; Godleski J; Richards W; Sugarbaker DJ; Rollins BJ
Cancer Res; 1995 Feb; 55(3):505-9. PubMed ID: 7834618
[TBL] [Abstract][Full Text] [Related]
4. Mutations of p16Ink4/CDKN2 and p15Ink4B/MTS2 genes in biliary tract cancers.
Yoshida S; Todoroki T; Ichikawa Y; Hanai S; Suzuki H; Hori M; Fukao K; Miwa M; Uchida K
Cancer Res; 1995 Jul; 55(13):2756-60. PubMed ID: 7796400
[TBL] [Abstract][Full Text] [Related]
5. Absence of p16INK4 protein is restricted to the subset of lung cancer lines that retains wildtype RB.
Otterson GA; Kratzke RA; Coxon A; Kim YW; Kaye FJ
Oncogene; 1994 Nov; 9(11):3375-8. PubMed ID: 7936665
[TBL] [Abstract][Full Text] [Related]
6. Suppression of growth in vitro and tumorigenicity in vivo of human carcinoma cell lines by transfected p16INK4.
Spillare EA; Okamoto A; Hagiwara K; Demetrick DJ; Serrano M; Beach D; Harris CC
Mol Carcinog; 1996 May; 16(1):53-60. PubMed ID: 8634094
[TBL] [Abstract][Full Text] [Related]
7. Expression of hTERT immortalises normal human urothelial cells without inactivation of the p16/Rb pathway.
Chapman EJ; Hurst CD; Pitt E; Chambers P; Aveyard JS; Knowles MA
Oncogene; 2006 Aug; 25(36):5037-45. PubMed ID: 16619045
[TBL] [Abstract][Full Text] [Related]
8. Association of rat p15INK4B/p16INK4 deletions with monosomy 5 in kidney epithelial cell lines but not primary renal tumors.
Knapek DF; Serrano M; Beach D; Trono D; Walker CL
Cancer Res; 1995 Apr; 55(8):1607-12. PubMed ID: 7712460
[TBL] [Abstract][Full Text] [Related]
9. Coincidental alterations of p16INK4A/CDKN2 and other genes in human lung cancer cell lines.
Fujishita T; Mizushima Y; Kashii T; Kobayashi M
Anticancer Res; 1998; 18(3A):1537-42. PubMed ID: 9673367
[TBL] [Abstract][Full Text] [Related]
10. CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated.
Ueki K; Ono Y; Henson JW; Efird JT; von Deimling A; Louis DN
Cancer Res; 1996 Jan; 56(1):150-3. PubMed ID: 8548755
[TBL] [Abstract][Full Text] [Related]
11. Association of extended in vitro proliferative potential with loss of p16INK4 expression.
Noble JR; Rogan EM; Neumann AA; Maclean K; Bryan TM; Reddel RR
Oncogene; 1996 Sep; 13(6):1259-68. PubMed ID: 8808700
[TBL] [Abstract][Full Text] [Related]
12. Lack of mutation in the cyclin-dependent kinase inhibitor, p19INK4d, in tumor-derived cell lines and primary tumors.
Zariwala M; Xiong Y
Oncogene; 1996 Nov; 13(9):2033-8. PubMed ID: 8934552
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical detection of the cyclin-dependent kinase inhibitor 2/multiple tumor suppressor gene 1 (CDKN2/MTS1) product p16INK4A in archival human solid tumors: correlation with retinoblastoma protein expression.
Geradts J; Kratzke RA; Niehans GA; Lincoln CE
Cancer Res; 1995 Dec; 55(24):6006-11. PubMed ID: 8521382
[TBL] [Abstract][Full Text] [Related]
14. Differential expression and cell cycle regulation of the cyclin-dependent kinase 4 inhibitor p16Ink4.
Tam SW; Shay JW; Pagano M
Cancer Res; 1994 Nov; 54(22):5816-20. PubMed ID: 7954407
[TBL] [Abstract][Full Text] [Related]
15. Loss of expression of the p16 tumor suppressor gene is more frequent in advanced ovarian cancers lacking p53 mutations.
Havrilesky LJ; Alvarez AA; Whitaker RS; Marks JR; Berchuck A
Gynecol Oncol; 2001 Dec; 83(3):491-500. PubMed ID: 11733961
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of bcl-2 is associated with p16INK4-mediated apoptosis in non-small cell lung cancer cells.
Kataoka M; Wiehle S; Spitz F; Schumacher G; Roth JA; Cristiano RJ
Oncogene; 2000 Mar; 19(12):1589-95. PubMed ID: 10734319
[TBL] [Abstract][Full Text] [Related]
17. 5'-Deoxy-5'-methylthioadenosine phosphorylase and p16INK4 deficiency in multiple tumor cell lines.
Della Ragione F; Russo G; Oliva A; Mastropietro S; Mancini A; Borrelli A; Casero RA; Iolascon A; Zappia V
Oncogene; 1995 Mar; 10(5):827-33. PubMed ID: 7898924
[TBL] [Abstract][Full Text] [Related]
18. Restoration of growth arrest by p16INK4, p21WAF1, pRB, and p53 is dependent on the integrity of the endogenous cell-cycle control pathways in human glioblastoma cell lines.
Costanzi-Strauss E; Strauss BE; Naviaux RK; Haas M
Exp Cell Res; 1998 Jan; 238(1):51-62. PubMed ID: 9457056
[TBL] [Abstract][Full Text] [Related]
19. TabBO: a model reflecting common molecular features of androgen-independent prostate cancer.
Navone NM; Rodriquez-Vargas MC; Benedict WF; Troncoso P; McDonnell TJ; Zhou JH; Luthra R; Logothetis CJ
Clin Cancer Res; 2000 Mar; 6(3):1190-7. PubMed ID: 10741751
[TBL] [Abstract][Full Text] [Related]
20. [Mutations of several tumor suppressor genes in primary retinoblastoma].
Huang Q; Tao Y; Yandell DW
Zhonghua Zhong Liu Za Zhi; 1999 Jan; 21(1):10-2. PubMed ID: 11776785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
